Research Paper Volume 14, Issue 12 pp 5233—5249

Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma


Figure 8. Associations between risk signature and immune checkpoints. (A) Expression of immune checkpoints among two risk subgroups in CM patients. Expression levels of genes PD-L1 (B) and PD-L2 (C) in risk subgroups. Correlation analysis between risk score, PD-L1 (D), and PD-L2 (E).